360° Coverage : Paid COPD Clinical Trial Now Enrolling at Avail Clinical...

1 Updates

Paid COPD Clinical Trial Now Enrolling at Avail Clinical Research Near Orlando, Florida; Accepting M/F Patients with COPD Age 40+

Sep 29 2013, 11:48am CDT | by PR.com

Avail is conducting a 24-week study to evaluate the effect of a once-daily experimental inhalation therapy on arterial stiffness compared to a placebo and another drug in subjects with Chronic Obstructive Pulmonary Disease (COPD).

DeLand, FL, September 29, 2013 --(PR.com)-- To see if you qualify for this COPD Clinical Trial in Florida, visit Avail Clinical Research on the web (http://www.availclinical.com) or contact us...

Filed under: news

YouTube Videos

 
 
 

1 year ago

Paid COPD Clinical Trial Now Enrolling at Avail Clinical Research Near Orlando, Florida; Accepting M/F Patients with COPD Age 40+

Sep 29 2013, 11:48am CDT | by PR.com

Avail is conducting a 24-week study to evaluate the effect of a once-daily experimental inhalation therapy on arterial stiffness compared to a placebo and another drug in subjects with Chronic Obstructive Pulmonary Disease (COPD).

DeLand, FL, September 29, 2013 --(PR.com)-- To see if you qualify for this COPD Clinical Trial in Florida, visit Avail Clinical Research on the web (http://www.availclinical.com) or contact us directly at (386) 785-2404. There is no cost to participate, no insurance is required, and you may receive compensation for time and travel.

Study Design
This study is designed to evaluate the effect of an experimental inhalation therapy administered once daily via a Novel Dry Powder Inhaler on arterial stiffness compared with placebo and vilanterol over a 24 - week treatment period in subjects with COPD. Vilanterol is included to help explain relative treatment effect of this experimental inhalation therapy in the new combination, however the comparison is not powered. Arterial stiffness will be measured as aPWV. This is a randomised, placebo-controlled, multicenter study. Subjects who meet the eligibility criteria at Screening and meeting the randomisation criteria at the end of a 2-week Run-In period will enter a 24-week treatment period. There will be an approximately 7-day Follow-Up period after the treatment period.

Background & Rationale
Arterial stiffness is increasingly recognized as a surrogate marker for cardiovascular disease (CVD). In particular, arterial stiffness has been shown to be an independent predictor of future fatal and non-fatal CV events and all-cause mortality in hypertensive patients, apparently healthy elderly subjects and a general population. Arterial stiffness can be measured with non-invasive, reproducible and inexpensive techniques, which make it feasible to implement into clinical practice and large-scale clinical studies.

Primary Objectives
The primary objective of the study is to evaluate the effect of an experimental inhalation therapy administered once daily (QD) compared with placebo on aPWV in subjects with COPD and aPWV ≥ 11.0 m/s at baseline.

Inclusion Criteria
1. Type of subject: outpatient
2. Informed consent: Subjects must give their signed and dated written informed consent to participate.
3. Gender: Male or female subjects

A female is eligible to enter and participate in the study if she is of:
-Non-child bearing potential (i.e., physiologically incapable of becoming pregnant, including any female who is post-menopausal or surgically sterile).
-Child bearing potential, has a negative pregnancy test at screening, and agrees to one of the following acceptable contraceptive methods used consistently and correctly:
-- Complete abstinence from intercourse from screening until the Follow-Up Phone Contact; or
-- Male partner is sterile (vasectomy with documentation of azoospermia) prior to female subject entry into the study, and this male partner is the sole partner for that subject; or
-- Implants of levonorgestrel inserted for at least 1 month prior to the study medication administration but not beyond the third successive year following insertion; or
-- Injectable progestogen administered for at least 1 month prior to study medication administration and administered until the Follow-Up Phone Contact; or
-- Oral contraceptive (combined or progestogen only) administered for at least one monthly cycle prior to study medication administration; or
-- Double barrier method: condom and occlusive cap (diaphragm or cervical/vault caps) with spermicidal agent (foam/gel/film/cream/suppository); or
-- An intrauterine device (IUD), inserted by a qualified physician, with published data showing that the highest expected failure rate is less than 1 per year; or
-- Estrogenic vaginal ring; or
-- Percutaneous contraceptive patches

4. Age: ≥40 years of age at Screening (Visit 1)
5. COPD diagnosis: Subjects with a clinical history of COPD
6. Tobacco use: Subjects with a current or prior history of ≥10 pack-years of cigarette smoking at Screening
7. Severity of Disease:

Subjects with a measured post-albuterol/salbutamol FEV1 ≤70% of predicted normal values calculated using NHANES III reference equations at Screening (Visit 1)
Subject with a measured post-albuterol/salbutamol FEV1/FVC ratio of ≤0.70 at Screening (Visit 1)
Post-bronchodilator spirometry will be performed approximately 10-15 minutes after
the subject has self-administered 4 inhalations (i.e., total 400mcg) of albuterol/salbutamol via an MDI with a valved-holding chamber.
8. Baseline aPWV: subjects with a measured aPWV≥11.0 m/s at Screening (Visit 1)

Contact Information:
Avail Clinical Research
Jennifer Economou
(386) 785-2400 336
Contact via Email
www.availclinical.com

Read the full story here: http://www.pr.com/press-release/518663

Press Release Distributed by PR.com

Source: PR.com

 

Don't miss ...

 

blog comments powered by Disqus

Latest stories

Japanese government concerned by yen's rapid fall against dollar
Tokyo, Nov 21 (IANS/EFE) Japanese Finance Minister Taro Aso Friday expressed concern over the sharp depreciation of the yen against the dollar this week, and said abrupt movements in the foreign exchange market were not beneficial to the Japanese economy.
 
 
WHO declares DRC Ebola-free
Geneva, Nov 21 (IANS) The World Health Organisation (WHO) Friday declared the end of the Ebola outbreak in the Democratic Republic of Congo (DRC).
 
 
Ultra rich population getting richer: Study
Washington, Nov 21 (IANS) Only 0.004 percent of the world's high networth adult population controls almost 13 percent of the world's total wealth, according to a new study.
 
 
Morocco, US organisation sign MoU on 'Enterprise City' project
Marrakech, Nov 21 (IANS) The Moroccan government and US institution Babson Global have signed a memorandum of understanding to conduct a feasibility study for the establishment of an "Enterprise City", a city dedicated to business, in the North African country.
 
 
 

Latest from the Network

Chinese court upholds life sentence against Uyghur activist
Beijing, Nov 21 (IANS/EFE) A court in western China has upheld the conviction and life sentence handed down against Uyghur activist Ilham Tohti, who appealed the sentence when it was first passed in September, one of...
Read more on Politics Balla
 
Matt Smith to star in Patient Zero
Matt Smith has been cast in 'Patient Zero'. The former 'Doctor Who' star has signed on to appear in the infection film which will see him have to cope with the aftermath of a worldwide viral pandemic across the Earth....
Read more on Movie Balla
 
Mick Jagger praises 'amazing' Chadwick Boseman
Sir Mick Jagger claims Chadwick Boseman is ''amazing'' as James Brown in the singer's biopic 'Get On Up'. The 71-year-old Rolling Stones rocker co-produced the movie and praised the young actor for his portrayal of the...
Read more on Movie Balla
 
South African president calls for end to racism in sports
Johannesburg, Nov 21 (IANS) South African President Jacob Zuma Friday called for global efforts to end racism in sports. South Africa adds its voice to the billions of others throughout the world who are determined to...
Read more on Sport Balla
 
Sheamus wants reality show for WWE Superstars
Sheamus wants to appear in a reality TV show about the WWE Superstars. The 36-year-old star believes the success of E! series 'Total Divas', which follows the lives of the female competitors in the company, has shown...
Read more on Celebrity Balla
 
Bill Murray: Actors are heroes
Bill Murray thinks actors are heroes. The 'Ghostbusters' star - who recently had an entire day dedicated to him at Toronto Film Festival - claims people admire actors so much because they get to escape reality by...
Read more on Celebrity Balla
 
Robin Williams' son: We're doing OK
Robin Williams' son says the late star's family are still adapting ''to the new normal'' following his father's death. The Hollywood actor died from asphyxia due to hanging at his home in August aged 63 and his eldest...
Read more on Celebrity Balla
 
Jennifer Lopez exfoliates with diamonds
Jennifer Lopez exfoliates her legs with diamonds. The 'On the Floor' hitmaker reportedly swears by a $250 Australian-made body scrub that is made with ''diamond powder'' to keep cellulite at bay. A source close to the...
Read more on Celebrity Balla
 
Indian golfers Atwal, Rashid tied 15th in Manila Masters
Manila, Nov 21 (IANS) Indian golfers Arjun Atwal and Rashid Khan shared the 15th position after the second round of the $1 million Manila Masters at the par-72 Manila Southwoods Golf and Country Club here Friday....
Read more on Sport Balla
 
Sarjubala, Saweety enter women's World boxing semis
Jeju (South Korea), Nov 21 (IANS) Indian boxers Shamjetsabam Sarjubala and Saweety reached the semi-finals of the Women's World Championships here Friday. Sarjubala started the proceedings with a dominating 3:0 win...
Read more on Sport Balla